MALASSEZIN
Mal•uh•say•zin
The discovery of Malassezin’s skincare benefits started with our hypothesis that this naturally occurring molecule found on skin might be effective for dark spots, but that was just the beginning of what we uncovered in our research.
Over six years, our founders and a team of scientists conducted extensive research, revealing that Malassezin dramatically reduces the appearance of dark spots, and also delivers powerful results for smoothing skin texture, minimizing the look of lines and wrinkles, supporting the skin barrier and protecting against free radical damage.
Over six years, our founders and a team of scientists conducted extensive research, revealing that Malassezin dramatically reduces the appearance of dark spots, and also delivers powerful results for smoothing skin texture, minimizing the look of lines and wrinkles, supporting the skin barrier and protecting against free radical damage.
POWER OF MALASSEZIN
10X MORE POWERFUL ANTIOXIDANT THAN VITAMIN C
10x more powerful at protecting against free radical damage, one of the top causes of skin aging, leaving skin brightened with even tone.
VISIBLY FADES HYPERPIGMENTATION IN THREE WAYS
In extensive lab testing and two clinical trials, Malassezin produced a significant reduction in the appearance of dark spots, sun spots, and other types of discoloration.
SMOOTHS AWAY FINE LINES AND WRINKLES
Decreases the breakdown of proteins in the skin to minimize fine lines and wrinkles and smooth the skin texture.
SUPPORTS THE SKIN BARRIER
Strengthens and calms the skin barrier enabling powerful benefits without irritation
PUBLISHED RESEARCH
Our scientific studies on Malassezin have been published in some of the top peer-reviewed dermatology journals.
JAAD
Journal of the American Academy of Dermatology 2021
Learn More
Our first in-person clinical study was published in the Journal of the American Academy of Dermatology, the official publication of the American Academy of Dermatology. This journal is one of the top peer-reviewed medical journals focused on dermatology. Our research underwent a rigorous, months-long review by leading dermatologists to ensure it met the high standards of the publication.
Read the full paper here.
Read the full paper here.
JDD
Journal of Drugs in Dermatology 2022
Learn More
Our first in-person clinical study was published in the top dermatology peer reviewed journal, the Journal of Drugs in Dermatology. The rigorous publication process includes articles being reviewed by an International Editorial Board. Our clinical study went above and beyond the industry standard and included facial biopsies and analysis of the skin over the course of five months.
Read the full paper here.
Read the full paper here.
EFFICACY
INNOVATION
CURIOSITY
DATA-DRIVEN
SCIENCE-LED
EFFICACY
INNOVATION
CURIOSITY
DATA-DRIVEN
SCIENCE-LED
EFFICACY
INNOVATION
CURIOSITY
DATA-DRIVEN
SCIENCE-LED
EFFICACY
INNOVATION
CURIOSITY
DATA-DRIVEN
SCIENCE-LED
EFFICACY
INNOVATION
CURIOSITY
DATA-DRIVEN
SCIENCE-LED
EFFICACY
INNOVATION
CURIOSITY
DATA-DRIVEN
SCIENCE-LED
EFFICACY
INNOVATION
CURIOSITY
DATA-DRIVEN
SCIENCE-LED
EFFICACY
INNOVATION
CURIOSITY
DATA-DRIVEN
SCIENCE-LED
EFFICACY
INNOVATION
CURIOSITY
DATA-DRIVEN
SCIENCE-LED
EFFICACY
INNOVATION
CURIOSITY
DATA-DRIVEN
SCIENCE-LED
EFFICACY
INNOVATION
CURIOSITY
DATA-DRIVEN
SCIENCE-LED
EFFICACY
INNOVATION
CURIOSITY
DATA-DRIVEN
SCIENCE-LED
EFFICACY
INNOVATION
CURIOSITY
DATA-DRIVEN
SCIENCE-LED
EFFICACY
INNOVATION
CURIOSITY
DATA-DRIVEN
SCIENCE-LED